Metabolic Complications Associated with HIV Protease Inhibitor Therapy

@article{Nolan2003MetabolicCA,
  title={Metabolic Complications Associated with HIV Protease Inhibitor Therapy},
  author={Dr David Nolan},
  journal={Drugs},
  year={2003},
  volume={63},
  pages={2555-2574}
}
HIV protease inhibitors were introduced into clinical practice over 7 years ago as an important component of combination antiretroviral drug regimens which in many ways revolutionised the treatment of HIV infection. The significant improvements in prognosis that have resulted from the use of these regimens, combined with the need for lifelong treatment, have increasingly focused attention on the adverse effects of antiretroviral drugs and on the metabolic complications of HIV protease… CONTINUE READING
23 Citations
84 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 84 references

Management of lipodystrophy, hyperlipidemia and insulin resistance in pa metabolic complications associated with antiretroviral therapy tients receiving protease inhibitors

  • M Schambelan, CA Benson, A Carr
  • AIDS
  • 1998
Highly Influential
6 Excerpts

Localised adipose tissue trophy: a 5-year cohort study

  • R Striker, D Conlin, M Marz
  • Arch Intern Med
  • 2000
Highly Influential
4 Excerpts

Buffalo hump’ in men with treatment with proteinase inhibitors

  • JC Lo, K Mulligan, VW Tai
  • Infection
  • 1999
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…